The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program

The aim of the study: to evaluate the cytokine profile state in pregnant women with non-alcoholic fatty liver disease (NAFLD) at the stage of non-alcoholic steatohepatitis (NASH) with varying degrees of obesity under the influence of the developed complex therapy program. Material and methods. We...

Full description

Bibliographic Details
Main Authors: L. V. Bahnii, S. M. Heriak, N. I. Bahnii
Format: Article
Language:English
Published: Zaporozhye State Medical University 2023-04-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/268274/271257
_version_ 1797851685908905984
author L. V. Bahnii
S. M. Heriak
N. I. Bahnii
author_facet L. V. Bahnii
S. M. Heriak
N. I. Bahnii
author_sort L. V. Bahnii
collection DOAJ
description The aim of the study: to evaluate the cytokine profile state in pregnant women with non-alcoholic fatty liver disease (NAFLD) at the stage of non-alcoholic steatohepatitis (NASH) with varying degrees of obesity under the influence of the developed complex therapy program. Material and methods. We examined 197 pregnant women with NAFLD at the stage of NASH in combination with obesity. The main group I consisted of 98 pregnant women with NAFLD at the stage of NASH with varying degrees of obesity, who were divided into 3 subgroups depending on body mass index (BMI). Among them, 26 pregnant women with BMI of 25.0–29.9 kg/m2 were included in IA group, 48 pregnant women with BMI of 30.0–34.9 kg/m2 were included in IB group, and 24 pregnant women with BMI of 35.0–39.9 kg/m2 – in IC group. All pregnant women in the main group were prescribed complex therapy including vitamin E at a dose of 400 IU/day, ursodeoxycholic acid (UDCA) at a dose of 15 mg/kg/day, and L-carnitine at a dose of 3 g per day. The comparison group consisted of 69 women with NAFLD at the stage of NASH and abdominal obesity, who corresponded to subgroups of the main group (IIA – 23 patients, IIB – 25 women, IIC – 21 pregnant women) and received basic therapy. The control group consisted of 30 healthy women. To evaluate the cytokine profile, levels of IL-1β, IL-6, IL-10 and TNF-α were determined by ELISPOT. Results. Analysis of the cytokine profile in women with NASH and obesity showed the presence of systemic inflammation links in the examined groups, which was manifested by increased levels of pro-inflammatory and decreased levels of anti-inflammatory interleukins in blood serum of pregnant women. A prescription of the complex treatment contributed to a decreased activity of the inflammatory response, which was manifested by an improvement in the levels of cytokine profile indicators. Conclusions. NASH during pregnancy is accompanied by significant changes in the cytokine profile. The prescription of complex therapy in the form of vitamin E, UDCA and L-carnitine is effective in the treatment of pregnant women with NAFLD at the stage of NASH due to cumulative and potentiating effects, reducing manifestations of systemic inflammation by normalizing the level of cytokines.
first_indexed 2024-04-09T19:21:51Z
format Article
id doaj.art-fb8d49d8a0b844f1a19d617555723b34
institution Directory Open Access Journal
issn 2306-4145
2310-1210
language English
last_indexed 2024-04-09T19:21:51Z
publishDate 2023-04-01
publisher Zaporozhye State Medical University
record_format Article
series Zaporožskij Medicinskij Žurnal
spelling doaj.art-fb8d49d8a0b844f1a19d617555723b342023-04-05T12:03:23ZengZaporozhye State Medical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102023-04-0125213614110.14739/2310-1210.2023.2.268274The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy programL. V. Bahnii0https://orcid.org/0000-0002-4224-0657S. M. Heriak1https://orcid.org/0000-0002-7894-1009N. I. Bahnii2https://orcid.org/0000-0003-1192-149XI. Horbachevsky Ternopil National Medical University of Health Ministry of UkraineIvan Horbachevsky Ternopil National Medical University of the Ministry of Health of UkraineIvan Horbachevsky Ternopil National Medical University of the Ministry of Health of UkraineThe aim of the study: to evaluate the cytokine profile state in pregnant women with non-alcoholic fatty liver disease (NAFLD) at the stage of non-alcoholic steatohepatitis (NASH) with varying degrees of obesity under the influence of the developed complex therapy program. Material and methods. We examined 197 pregnant women with NAFLD at the stage of NASH in combination with obesity. The main group I consisted of 98 pregnant women with NAFLD at the stage of NASH with varying degrees of obesity, who were divided into 3 subgroups depending on body mass index (BMI). Among them, 26 pregnant women with BMI of 25.0–29.9 kg/m2 were included in IA group, 48 pregnant women with BMI of 30.0–34.9 kg/m2 were included in IB group, and 24 pregnant women with BMI of 35.0–39.9 kg/m2 – in IC group. All pregnant women in the main group were prescribed complex therapy including vitamin E at a dose of 400 IU/day, ursodeoxycholic acid (UDCA) at a dose of 15 mg/kg/day, and L-carnitine at a dose of 3 g per day. The comparison group consisted of 69 women with NAFLD at the stage of NASH and abdominal obesity, who corresponded to subgroups of the main group (IIA – 23 patients, IIB – 25 women, IIC – 21 pregnant women) and received basic therapy. The control group consisted of 30 healthy women. To evaluate the cytokine profile, levels of IL-1β, IL-6, IL-10 and TNF-α were determined by ELISPOT. Results. Analysis of the cytokine profile in women with NASH and obesity showed the presence of systemic inflammation links in the examined groups, which was manifested by increased levels of pro-inflammatory and decreased levels of anti-inflammatory interleukins in blood serum of pregnant women. A prescription of the complex treatment contributed to a decreased activity of the inflammatory response, which was manifested by an improvement in the levels of cytokine profile indicators. Conclusions. NASH during pregnancy is accompanied by significant changes in the cytokine profile. The prescription of complex therapy in the form of vitamin E, UDCA and L-carnitine is effective in the treatment of pregnant women with NAFLD at the stage of NASH due to cumulative and potentiating effects, reducing manifestations of systemic inflammation by normalizing the level of cytokines.http://zmj.zsmu.edu.ua/article/view/268274/271257non-alcoholic steatohepatitiscytokine profileobesitypregnancy complicationsvitamin eursodeoxycholic acid
spellingShingle L. V. Bahnii
S. M. Heriak
N. I. Bahnii
The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program
Zaporožskij Medicinskij Žurnal
non-alcoholic steatohepatitis
cytokine profile
obesity
pregnancy complications
vitamin e
ursodeoxycholic acid
title The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program
title_full The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program
title_fullStr The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program
title_full_unstemmed The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program
title_short The state of the cytokine profile in pregnant women with non-alcoholic fatty liver disease at the stage of non-alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program
title_sort state of the cytokine profile in pregnant women with non alcoholic fatty liver disease at the stage of non alcoholic steatohepatitis with varying degrees of comorbid obesity under the influence of the developed complex therapy program
topic non-alcoholic steatohepatitis
cytokine profile
obesity
pregnancy complications
vitamin e
ursodeoxycholic acid
url http://zmj.zsmu.edu.ua/article/view/268274/271257
work_keys_str_mv AT lvbahnii thestateofthecytokineprofileinpregnantwomenwithnonalcoholicfattyliverdiseaseatthestageofnonalcoholicsteatohepatitiswithvaryingdegreesofcomorbidobesityundertheinfluenceofthedevelopedcomplextherapyprogram
AT smheriak thestateofthecytokineprofileinpregnantwomenwithnonalcoholicfattyliverdiseaseatthestageofnonalcoholicsteatohepatitiswithvaryingdegreesofcomorbidobesityundertheinfluenceofthedevelopedcomplextherapyprogram
AT nibahnii thestateofthecytokineprofileinpregnantwomenwithnonalcoholicfattyliverdiseaseatthestageofnonalcoholicsteatohepatitiswithvaryingdegreesofcomorbidobesityundertheinfluenceofthedevelopedcomplextherapyprogram
AT lvbahnii stateofthecytokineprofileinpregnantwomenwithnonalcoholicfattyliverdiseaseatthestageofnonalcoholicsteatohepatitiswithvaryingdegreesofcomorbidobesityundertheinfluenceofthedevelopedcomplextherapyprogram
AT smheriak stateofthecytokineprofileinpregnantwomenwithnonalcoholicfattyliverdiseaseatthestageofnonalcoholicsteatohepatitiswithvaryingdegreesofcomorbidobesityundertheinfluenceofthedevelopedcomplextherapyprogram
AT nibahnii stateofthecytokineprofileinpregnantwomenwithnonalcoholicfattyliverdiseaseatthestageofnonalcoholicsteatohepatitiswithvaryingdegreesofcomorbidobesityundertheinfluenceofthedevelopedcomplextherapyprogram